This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Old Republic (ORI) Board OKs Special Dividend, Share Buyback
by Zacks Equity Research
Old Republic's (ORI) special, one-time cash dividend of $1 per share and $450 million share buyback approval reflects its solid financial foundation and operational performance.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Continued mobile subscriber growth, organic growth across distribution channels and effective capital deployment continue to drive Assurant (AIZ).
Reasons Why MGIC Investment (MTG) Stock is an Attractive Pick
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields, and prudent capital deployment.
Is Old Republic International (ORI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna Corporation (CI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Old Republic International (ORI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 15% and 5.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q2 Earnings Lag Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -5.88% and 4.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Old Republic International (ORI) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of -10% and 0.79%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Stay Invested in Old Republic (ORI)
by Zacks Equity Research
Old Republic International Corporation (ORI) is poised for growth on solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and robust capital position.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators are part of today's industry outlook article.
Why Should You Hold Aon's (AON) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on cost-cutting initiatives, strategic measures and a better bottom line, Aon (AON) holds potential to reap benefits for investors.
5 Multiline Insurers to Watch as Pandemic Impact Recedes
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, ORI and HMN as the impact of the pandemic recedes.
Why is Hold Strategy Appropriate for CNO Financial (CNO)?
by Zacks Equity Research
CNO Financial (CNO) has enough potential to reap benefits for investors owing to strong investments in technology and cost-cutting measures.
Here's Why You Should Hold on to Trupanion (TRUP) Stock Now
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given the change in the attitude of pet owners who are increasingly focusing on pets' health and well-being.
MetLife (MET) Unit Hits Milestone in Agricultural Mortgage Loans
by Zacks Equity Research
MetLife (MET) business unit MetLife Investment Management (MIM) creates a record by originating $6 billion in agricultural mortgage loans during 2021.
CME Group (CME) Unveils Micro-Sized Bitcoin and Ether Options
by Zacks Equity Research
CME Group (CME) introduces Micro Bitcoin and Micro Ether futures to add to the existing suite of cryptocurrency derivative offerings.
AIG Rebrands Life & Retirement, Eyes IPO, Ropes in BlackRock
by Zacks Equity Research
American International Group's (AIG) Life and Retirement business is set to be rebranded as Corebridge Financial and is reportedly valued at around $20 billion.
Should You Retain Prudential Financial (PRU) Stock Now?
by Zacks Equity Research
Prudential Financial (PRU) benefits from higher net investment spread and fee income, favorable underwriting results, and effective capital deployment.
Here's Why You Should Hold on to Argo Group (ARGO) Stock Now
by Zacks Equity Research
Argo Group's (ARGO) highly profitable businesses, exiting reinsurance operations and non-core lines of business, lowering property exposure substantially and reducing volatility bodes well for growth.
Here's Why You Should Hold on to Assurant (AIZ) Stock for Now
by Zacks Equity Research
Assurant (AIZ) is set to gain on solid segmental performance and sufficient liquidity.
Here's Why You Should Hold Hartford Financial (HIG) Stock
by Zacks Equity Research
Riding high on acquisitions and divestitures along with restructuring initiatives, Hartford Financial (HIG) has enough potential to reap benefits for investors.
Should Value Investors Buy Old Republic International (ORI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna Corp. (CI) Up 7.8% in 3 Months: More Room to Grow?
by Zacks Equity Research
Cigna Corp. (CI) expects to buy back more than $7 billion worth of shares in 2022.
MetLife (MET) Ties Up to Offer Better Pet Care With New Program
by Zacks Equity Research
MetLife (MET) collaborates with LifeBalance for launching MyPets rewards program in a bid to offer pet parents substantial savings while purchasing pet care commodities.
Old Republic (ORI) Rises 15% in a Year: More Upside Left?
by Zacks Equity Research
Solid market presence, niche focus, low property catastrophe exposure at its General Insurance segment and solid capital position continue to drive Old Republic (ORI).